Research programme: thrombosis therapeutics - Lexicon Genetics
Alternative Names: LG101 inhibitors research programme - Lexicon Genetics; LG110 inhibitors research programme - Lexicon Genetics; Thrombosis therapeutics research programme - Lexicon GeneticsLatest Information Update: 02 May 2007
At a glance
- Originator Lexicon Genetics
- Developer Lexicon Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 02 May 2007 No development reported - Preclinical for Thrombosis in USA (unspecified route)
- 07 Sep 2005 This programme is still in active development
- 16 Jun 2003 Preclinical trials in Thrombosis in USA (unspecified route)